Loading...

Daily news and top headlines for medical design professionals

FREE Email Newsletter View Sample


Regulatory News

Gris-PEG (griseofulvin ultramicrosize): Health Advisory - Risk of Product Mix-Up

11 hours ago | News

During packaging and labeling, tablets from one product type may have carried over into packaging of another product.

Acetylcysteine Solution, USP (Roxane Laboratories, Inc.): Recall - Visible Glass Particle

18 hours ago | News

Use of an inhaled product with glass particles has the potential to cause choking which could be life-threatening.

Summary Information for: Therapy Cool Path Duo? Ablation Catheter, Safire BLU Duo? Ablation Catheter, and IBI1500T9-CP V1.6 Cardiac Ablation Generator

Feb 2 | News

Labeling, Approval Order, and Summary of Safety and Effectiveness for Therapy Cool Path Duo? Ablation Catheter, Safire BLU Duo? Ablation Catheter, and IBI1500T9-CP V1.6 Cardiac Ablation Generator (P110016).

Consumer Information on: Therapy Cool Path Duo? Ablation Catheter, Safire BLU Duo? Ablation Catheter, and IBI1500T9-CP V1.6 Cardiac Ablation Generator - P110016

Feb 2 | News

The Therapy Cool Path Duo? Ablation Catheter or the Safire BLU Duo? Ablation Catheter is a steerable, deflectable, irrigated catheter (a long, thin, flexible tube) used to treat a certain kind of abnormal heart rhythm (arrhythmia2) called typical atrial..

Extended Sunshine Act Deadline Provides Extra Time for Pharma, Biotech and Device Companies to Track and Report Physician Payments

Feb 1 | News

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--As the industry awaits the release of the delayed Sunshine Act guidelines, pharmaceutical and medical device companies are benefiting from the extra time by reviewing current physician payment reporting structures...

FDA and industry reach agreement in principle on medical device user fees

Feb 1 | News

The FDA and representatives from the medical device industry have reached an agreement in principle on proposed recommendations for the third reauthorization of a medical device user fee program. The recommendations would authorize the FDA to collect $595 million in user fees...

Lo/Ovral-28 (Norgestrel/EthinylEstradiol) Tablets: Recall - Possibility of Inexact Tablet Counts or Out of Sequence Tablets

Feb 1 | News

Oral contraceptive daily regimen may be incorrect and could leave women without adequate contraception, and at risk for unintended pregnancy.

Vitaflo USA Renastart: Recall - Possible Health Risk Due To Incorrectly Labeled Cans

Jan 31 | News

Consequences of using the incorrectly labeled product may result in high potassium blood levels (hyperkalemia) or high sodium levels in the blood (hypernatremia).

Treanda (bendamustine HCL): Recall - Particulate Matter in Vial

Jan 30 | News

Potential adverse events after intravenous administration of solutions containing particulates may include emboli and result in disruption of blood flow, causing tissue/organ damage.

CDRH: Priorities This Year Include Product Lifecycle, Helping Innovation

Jan 27 | News

CDRH’s 2012 priorities include a strong focus on innovation and the device approval process, a strategic report shows.

Congressional Democrats Call for Hearings on Hazardous Medical Devices

Jan 27 | News

House Democrats are urging the Committee on Energy and Commerce to hold hearings on whether the FDA and device industry are doing all they can to protect consumers from unsafe products.

Consumer Information on: M-Vu Algorithm Engine - P100005

Jan 27 | News

The M-Vu Algorithm Engine is a software application designed to process digitized film images of the breast. The software analyzes the images and marks suspicious areas consistent with breast cancer for review by a radiologist. The results are displayed o

Summary Information for: M-Vu Algorithm Engine

Jan 27 | News

Labeling, Approval Order, and Summary of Safety and Effectiveness for M-Vu Algorithm Engine (P100005).

Summary Information for: MelaFind®

Jan 25 | News

Labeling, Approval Order, and Summary of Safety and Effectiveness for MelaFind® (P090012).

Suspension Orthopaedics Gets FDA Clearance for Surgical System

Jan 25 | News

ARNOLD, MD - Suspension Orthopaedic Solutions announced it has received FDA 510(k) clearance for two new products - its Distal Clavicle Fracture Fixation System™ and a new plate designed to address repair of mid-shaft clavicle fractures. The new Distal Clavicle Fracture Fixation System features...

Consumer Information on: ADVIA® Centaur Anti-HBs2 (aHBs2) Assay and ADVIA® Centaur Anti-HBs2 (aHBs2) Quality Control Material for use on the ADVIA® Centaur and ...

Jan 24 | News

ADVIA Centaur Anti-HBs2 (aHBs2) assay is a laboratory test used to detect antibodies associated with hepatitis B virus (HBV) infection.

Summary Information for: ADVIA® Centaur Anti-HBs2 (aHBs2) Assay and ADVIA® Centaur Anti-HBs2 (aHBs2) Quality Control Material for use on the ADVIA® Centaur and ...

Jan 24 | News

Labeling, Approval Order, and Summary of Safety and Effectiveness for ADVIA® Centaur Anti-HBs2 (aHBs2) Assay and ADVIA® Centaur Anti-HBs2 (aHBs2) Quality Control Material for use on the ADVIA® Centaur and ADVIA® Centaur XP Systems (P100039).

Loading...




Loading...
<!-- Insert your title here -->

Free Subscriptions
for medical device design engineers

Magazine

wireless week

Newsletters

newsletters

Sign up now



Video of the Day


Top Stories and Headlines
EVERY DAY!

FREE Email Newsletter